Lori E. Heath

A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events

Matthew M. Heeney, Carolyn Hoppe, Miguel R. Abboud et al. · New England Journal of Medicine · 2015 · 145 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease

Ted Wun, Denis Soulières, Andrew L. Frelinger et al. · Journal of Hematology & Oncology · 2013 · 70 citations · Full text

Medicine, Hematology, Pharmacology +17

Prasugrel in Children With Sickle Cell Disease

Lori Styles, Darell Heiselman, Lori E. Heath et al. · Journal of Pediatric Hematology/Oncology · 2014 · 26 citations

Medicine, Pharmacology, Pharmacotherapy +17

Cognitive Testing of an Electronic Version of the Faces Pain Scale-Revised with Pediatric and Adolescent Sickle Cell Patients

Neehar Gupta, April N. Naegeli, Diane M. Turner‐Bowker et al. · Patient · 2016 · 18 citations · Full text

Medicine, Child Health, Pediatrics +17

Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso‐Occlusive Events) trial: A global Phase 3 double‐blind, randomized, placebo‐controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy

Carolyn Hoppe, Lori Styles, Lori E. Heath et al. · Pediatric Blood & Cancer · 2015 · 16 citations

Medicine, Cardiology, Pharmacology +17